Soleo Health, an innovative leader in specialty infusion services, announced the company has been selected by Genentech (member of the Roche Group), a world-leading biotechnology company with multiple products on the market and a strong development pipeline, to dispense two limited distribution drug
Rite Aid Corp. announced that starting Sunday, July 1, Rite Aid pharmacists at all locations in Idaho will be able to prescribe medications to treat select, common conditions, under the Pharmacist Prescriptive Authority Rule Docket 27-0104-1701 promulgated by the Idaho State Board of Pharmacy.
MinuteClinic, the retail medical clinic of CVS Health, is encouraging unvaccinated Ohio residents to receive the hepatitis A vaccine following an increase in confirmed cases of the virus.
Genentech announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for baloxavir marboxil as a single-dose, oral treatment for acute, uncomplicated influenza in people 12 years and older.
The U.S. Food and Drug Administration has approved a marijuana-derived drug for the treatment of two rare and serious forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, that begin in childhood but can persist in adulthood.
Aurobindo Pharma announced that the company has received final approval from the U.S. Food & Drug Administration to manufacture and market ertapenem injection 1 g/vial. Aurobindo’s ertapenem injection is a generic equivalent of Merck Sharp & Dohme Corp’s Invanz Injection.
Eli Lilly’s ultra rapid lispro (URLi) led to improved and sustained blood sugar control after meals in people with type 1 and type 2 diabetes, according to results from three phase 1b studies evaluating URLi compared to Humalog.
AllianceRx Walgreens Prime, the combined central specialty and home delivery pharmacy formed by Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime) announced today a collaboration with Inovalon, a leading technology company providing cloud-based platforms empowering data-driven hea
Today, the U.S. House of Representatives passed a legislative package, SUPPORT for Patients and Communities Act (H.R. 6), which requires electronic prescribing (e-prescribing) of controlled substances in Medicare.
ARLINGTON, Va. – Legislation backed by the National Association of Chain Drug Stores (NACDS) to help address the opioid abuse epidemic was passed today by the House of Representatives. The bill – the Every Prescription Conveyed Securely Act (H.R.
CVS Health has issued the following statement regarding Ohio Department of Medicaid’s report on PBM performance for managed care plans: “CVS Health is pleased that a report issued today that was commissioned by the Ohio Department of Medicaid (ODM) on pharmacy benefit manager (PBM) performance for t
Pharmacy Quality Solutions (PQS), a leading provider of quality measurement and performance information for payer and pharmacy organizations, is helping pharmacies improve the quality of medication use for patients through its flagship platform EQuIPP.
CVS Health president and chief executive officer Larry Merlo will join an exceptional mix of business experts and thought leaders who will share their insights on the accelerated pace of change in health care and how innovation, investments in technology, emerging business models and new competition
CVS Health has expanded its safe medication disposal program to select CVS Pharmacy locations in Arizona to help facilitate proper and timely disposal of opioids and other medications that could be diverted or misused if left in medicine cabinets.
CVS Pharmacy announced that prescription delivery is now available from CVS Pharmacy locations nationwide.
New research from Avalere finds that the amount of prescription opioids sold across the US declined by 11% in 2017 compared to 2016.
